Advertisement
Screener

Tevogen Inc. (TVGN) Material Contracts

Tevogen Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-09-16: Form 8-K; Exhibit 10.1; Description Form of Restricted Stock Award Agreement, dated September 14, 2026, under Tevogen Inc. 2024 Omnibus Incentive Plan.
  • 2026-08-26: Form 8-K; Exhibit 10.1; Description Amendment No. 2 to the Tevogen Inc. 2024 Omnibus Incentive Plan.
  • 2026-05-15: Form 10-Q; Exhibit 10.2; Description Securities Purchase Agreement, dated May 11, 2026, between the Company and The Patel Family, LLP.
  • 2026-02-25: Form 8-K; Exhibit 10.1; Description Amendment No. 1 to the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan.
FiledFormExhibitDescription
2026-09-168-K10.1Form of Restricted Stock Award Agreement, dated September 14, 2026, under Tevogen Inc. 2024 Omnibus Incentive Plan
2026-08-268-K10.1Amendment No. 2 to the Tevogen Inc. 2024 Omnibus Incentive Plan
2026-05-1510-Q10.2Securities Purchase Agreement, dated May 11, 2026, between the Company and The Patel Family, LLP
2026-02-258-K10.1Amendment No. 1 to the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan
2025-06-038-K10.1Amendment No. 1 to the Lease Agreement, dated as of May 30, 2025, between Mitsui Sumitomo Insurance Company of America and Tevogen Bio Inc.
2024-08-238-K10.1Securities Purchase Agreement, dated as of August 21, 2024, by and among Tevogen Bio Holdings Inc. and The Patel Family, LLP
2024-06-218-K10.1Preferred Stock Repurchase Agreement, dated June 15, 2024, by and between Tevogen Bio Holdings Inc. and SSVK Associates, LLC
2024-06-118-K10.1Loan Agreement, dated as of June 6, 2024, between Tevogen Bio Holdings Inc. and The Patel Family, LLP
2024-04-2910-K10.15Service Agreement, dated as of April 15, 2022, between Tevogen Bio Inc and CIC Innovation Communities, LLC (incorporated by reference to Exhibit 10.15 to Amendment No. 2 to the Registration Statement on Form S-4 (Registration No. 333-274519) filed with the SEC on November 22, 2023)
2024-04-2910-K10.14Restricted Stock Unit Agreement, dated as of February 14, 2024, by and between the Company and Ryan Saadi
2024-04-2910-K10.13Amendment to Assignment and Assumption Agreement, dated as of March 15, 2024, by and between the Company and SSVK Associates, LLC
2024-04-2910-K10.8Non-Competition and Non-Solicitation Agreement, effective as of February 14, 2024, by and between the Company and Ryan Saadi
2024-04-2910-K10.7Lock-Up Agreement, dated February 14, 2024, between the Company, SSVK Associates, LLC, Ryan Saadi, and the other signatories thereto
2024-04-2910-K10.6Amended and Restated Registration Rights Agreement, dated February 14, 2024, by and among the Company, SSVK Associates, LLC, Semper Paratus Sponsor LLC, Cantor Fitzgerald & Co., and the other signatories thereto
2024-04-2910-K10.5Amendment to Letter Agreement, dated February 13, 2024, by and among the Company, its officers, its directors, SVKK Associates, LLC, and Semper Paratus Sponsor LLC
2024-04-028-K10.1Amended and Restated Securities Purchase Agreement, dated as of March 27, 2024, by and among Tevogen Bio Holdings Inc. and The Patel Family, LLP
2024-02-208-K/A10.11Assignment and Assumption Agreement, dated as of February 14, 2024, by and between Semper Paratus Acquisition Corporation and SSVK Associates, LLC.
2024-02-148-K10.10Form of Indemnification Agreement.
2024-02-148-K10.9Form of Restricted Stock Unit Agreement
2024-02-148-K10.8Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan.
2024-02-148-K10.7Assignment and Assumption Agreement, dated February 14, 2024, by and between Semper Paratus Acquisition Corporation and Tevogen Bio Inc.
2024-02-148-K10.6Non-Competition and Non-Solicitation Agreement, by and between Semper Paratus Acquisition Corporation and Ryan Saadi.
2024-02-148-K10.5Lock-Up Agreement, dated February 14, 2024, between the Company, Semper Paratus, SSVK Associates, LLC, Ryan Saadi, and the other signatories thereto.
2024-02-148-K10.4Amended and Restated Registration Rights Agreement, dated February 14, 2024, by and among the Company, SSVK Associates, LLC, Semper Paratus Sponsor LLC, Cantor Fitzgerald & Co., and the other signatories thereto.
2023-08-2110-Q10.4Fee Reduction Agreement, dated June 28, 2023, by and among Semper Paratus Acquisition Corporation and Cantor Fitzgerald & Co.
2023-08-2110-Q10.3Subscription Agreement, dated June 20, 2023, by and among Semper Paratus Acquisition Corporation, Semper Paratus Sponsor LLC and Polar Multi-Strategy Master Fund
2023-05-098-K10.2Purchase Agreement, dated May 4, 2023, by and among SSVK Associates, LLC, Semper Paratus Acquisition Corporation and Semper Paratus Sponsor LLC.
2023-05-098-K10.1Subscription Agreement, dated May 3, 2023, by and among Semper Paratus Acquisition Corporation, Semper Paratus Sponsor LLC and Polar Multi-Strategy Master Fund.
2021-11-088-K10.7Administrative Support Agreement, dated November 3, 2021, by and between the Company and the Sponsor.
2021-11-088-K10.6Form of Indemnity Agreement, dated November 3, 2021, by and among the Company and each of the directors and officers of the Company.
2021-11-088-K10.5Unit Subscription Agreement, dated November 3, 2021, by and between the Company and Cantor Fitzgerald & Co.
2021-11-088-K10.4Private Placement Units Purchase Agreement, dated November 3, 2021, by and between the Company and the Sponsor.
2021-11-088-K10.3Registration and Shareholder Rights Agreement, dated November 3, 2021, by and between the Company, the Sponsor and Cantor Fitzgerald & Co.
2021-11-088-K10.2Investment Management Trust Agreement, dated November 3, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as trustee.
2021-11-088-K10.1Letter Agreement, dated November 3, 2021, by and among the Company, its officers, its directors and the Sponsor.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Instil Bio, Inc. (TIL)United States$0.048B-1.73
LeonaBio, Inc. (LONA)United States$0.047B-0.61
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
ImageneBio, Inc. (IMA)United States$0.056B-1.31
Scilex Holding Co (SCLX)United States$0.042B-0.14
BioAtla, Inc. (BCAB)United States$0.058B-0.21
EXOZYMES INC. (EXOZ)United States$0.058B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B